4

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: November 21, 2003
Period of Report: November 21, 2003
Accession Number: 0001247741-03-000005

View Document ↗ View on SEC.gov ↗